These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1352738)

  • 1. Thapsigargin, an inhibitor of Ca(2+)-ATPase, antagonizes vacuole formation of hepatoma cells induced by teleocidin.
    Tsukamoto A; Kaneko Y; Kurokawa K
    Cell Biol Int Rep; 1992 May; 16(5):491-2. PubMed ID: 1352738
    [No Abstract]   [Full Text] [Related]  

  • 2. Thapsigargin, an inhibitor of endoplasmic reticulum Ca(2+)-ATPase, enhances c-fos expression but antagonizes vacuole formation of human hepatoma cells induced by teleocidin.
    Tsukamoto A; Kaneko Y; Kurokawa K
    Biochim Biophys Acta; 1993 May; 1177(1):31-6. PubMed ID: 8485167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tumor promoters (mezerein, teleocidin and palytoxin) on growth hormone secretion from rat anterior pituitary cells cultured in monolayer.
    Ohmura E; Tsushima T; Emoto N; Obuchi E; Shizume K
    Life Sci; 1987 Aug; 41(6):691-6. PubMed ID: 2886871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thapsigargin, a Ca(2+)-ATPase inhibitor, depletes the intracellular Ca2+ pool and induces apoptosis in human hepatoma cells.
    Tsukamoto A; Kaneko Y
    Cell Biol Int; 1993 Oct; 17(10):969-70. PubMed ID: 8287027
    [No Abstract]   [Full Text] [Related]  

  • 5. Analyses of gene regulatory signal transduction pathways by use of novel types of tumor promoters.
    Schönthal A
    Adv Second Messenger Phosphoprotein Res; 1993; 28():211-8. PubMed ID: 8398406
    [No Abstract]   [Full Text] [Related]  

  • 6. [The actions of TPA-type as well as non-TPA type tumor promoters and their mechanism(s) in tumor promotion].
    Fujiki H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):758-65. PubMed ID: 2870684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin.
    Fujiki H; Sugimura T
    Adv Cancer Res; 1987; 49():223-64. PubMed ID: 2890278
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential activation and inhibition of lymphocyte proliferation by phorbol esters, mezerein, teleocidin, and okadaic acid.
    Grove DS; Mastro AM
    Cancer Res; 1991 Jan; 51(1):82-8. PubMed ID: 1988110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in the chemical nature and mechanism of response to tumor promoters.
    Fujiki H; Suganuma M; Suguri H; Yoshizawa S; Hirota M; Takagi K; Sugimura T
    Prog Clin Biol Res; 1989; 298():281-91. PubMed ID: 2568638
    [No Abstract]   [Full Text] [Related]  

  • 10. Vacuole formation and cytokeratin rearrangement of hepatoma cells induced by teleocidin are not associated with down-regulation of protein kinase C.
    Kaneko Y; Tsukamoto A; Kurokawa K
    Cancer Res; 1991 May; 51(10):2677-82. PubMed ID: 1708698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of phospholipase D in SH-SY5Y neuroblastoma cells: dependence on Ca2+ and protein kinase C.
    Purkiss JR
    Biochem Soc Trans; 1995 Aug; 23(3):427S. PubMed ID: 8566315
    [No Abstract]   [Full Text] [Related]  

  • 12. An activated mutant of the alpha subunit of G(o) increases neurite outgrowth via protein kinase C.
    Xie R; Li L; Goshima Y; Strittmatter SM
    Brain Res Dev Brain Res; 1995 Jun; 87(1):77-86. PubMed ID: 7554235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of tyrosine- and serine/threonine kinases in the transcriptional activation of the mammalian grp78/BiP promoter by thapsigargin.
    Cao X; Zhou Y; Lee AS
    J Biol Chem; 1995 Jan; 270(1):494-502. PubMed ID: 7814417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thapsigargin activates lymphocytes via a different pathway from ionomycin.
    Fenton M; Kay JE
    Biochem Soc Trans; 1993 Nov; 21(4):391S. PubMed ID: 7510649
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation by protein kinase C of platelet-activating factor- and thapsigargin-induced calcium entry in rabbit neutrophils.
    Shibata K; Kitayama S; Morita K; Shirakawa M; Okamoto H; Dohi T
    Jpn J Pharmacol; 1994 Oct; 66(2):273-6. PubMed ID: 7869612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of ATP binding inhibition to the sarcoplasmic reticulum Ca(2+)-ATPase by thapsigargin.
    DeJesus F; Girardet JL; Dupont Y
    FEBS Lett; 1993 Oct; 332(3):229-32. PubMed ID: 8405462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
    Suganuma M; Fujiki H; Suguri H; Yoshizawa S; Hirota M; Nakayasu M; Ojika M; Wakamatsu K; Yamada K; Sugimura T
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1768-71. PubMed ID: 3126494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thapsigargin, a Ca(2+)-ATPase inhibitor, relaxes rat aorta via nitric oxide formation.
    Moritoki H; Hisayama T; Kondoh W; Takeuchi S
    Life Sci; 1994; 54(9):PL153-8. PubMed ID: 8114611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of superoxide anion formation by the non-TPA type tumor promoters palytoxin and thapsigargin in porcine and human neutrophils.
    Kano S; Iizuka T; Ishimura Y; Fujiki H; Sugimura T
    Biochem Biophys Res Commun; 1987 Mar; 143(2):672-7. PubMed ID: 2882751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic structure of the rice aldolase isozyme C-1 gene and its regulation through a Ca 2+ -mediated protein kinase-phosphatase pathway.
    Nakamura H; Satoh W; Hidaka S; Kagaya Y; Ejiri S; Tsutsumi K
    Plant Mol Biol; 1996 Jan; 30(2):381-5. PubMed ID: 8616263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.